The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
Paper No. 42
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte JAMES E. DARNELL JR.,
CHRISTIAN W. SCHINDLER,
XIN-YUAN FU,
ZILONG WEN, and
ZHONG ZHONG
__________
Appeal No. 2001-0121
Application No. 08/212,185
__________
ON BRIEF
__________
Before WINTERS, SCHEINER, and ADAMS, Administrative Patent Judges.
ADAMS, Administrative Patent Judge.
DECISION ON APPEAL
This is a decision on the appeal under 35 U.S.C. § 134 from the
examiner’s final rejection of claims 96-103, which are all the claims pending in
the application.
Claims 100 and 103 are illustrative of the subject matter on appeal and
are reproduced below:
100. A method of identifying a potential drug having the ability to
modulate the binding of an activated receptor recognition factor to
a DNA ligand in vitro comprising:
(a) contacting a small molecule with a purified activated
receptor recognition factor; wherein in the absence of the
small molecule the purified activated receptor recognition
factor is able to bind to the DNA ligand in vitro;
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next
Last modified: November 3, 2007